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http://dxObjective: To retrospectively evaluate the technical feasibility and midterm results of uncovered thoraco-
abdominal stent placement in complicated acute aortic dissection Stanford type B (cAADB).
Patients and Methods: Fourteen consecutive patients (3 females; range, 44-71 years) with cAADB who had
symptomatic gastrointestinal malperfusion and claudication underwent immediate uncovered stent implantation
(diameter, 7-28 mm; length, 40-100 mm) into the true lumen of the thoracoabdominal aorta (n¼ 23) and visceral
arteries (n ¼ 5).
Results: Stenting resulted in elimination of gastrointestinal ischemia and symptoms in 13 of 14 patients;
persisting symptoms led to secondary surgical revascularization in only 1 patient. More than 1 stent (4)
was placed in 7 patients (2 celiac, 1 mesenteric, 2 renal, 8 aorto-iliac). Follow-up computed tomographic
angiography (CTA) revealed collapse of 4 aortic stents (diameter, 9-25 mm; length, 100 mm) at 1 week in
the absence of symptoms. Balloon reexpansion was possible in all 4 stents, but recollapse occurred within 1
month. Despite stent collapse, the patients remained asymptomatic; ultrasonography and CTA documented
sufficient perfusion of the visceral arteries in all patients. Follow-up ranged from 6 months to 5 years (average,
2.5 years). Except for the patient who underwent iliacomesenteric bypass for unspecific abdominal pain, no
other patient required additional interventional or surgical therapy.
Conclusions: Acute aortic dissection with suspicion of visceral ischemia should prompt for immediate
intervention. Thoracoabdominal uncovered stent implantation is a technically feasible and effective minimally
invasive approach that provided successful relief of acute visceral ischemia and claudication in cAADB. Stent
size should be less than the normal aortic diameter to avoid possible stent collapse. (J Thorac Cardiovasc Surg
2014;148:3003-11)See related commentary on pages 3012-3.
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DAcute aortic dissection type B is commonly treated
conservatively in the absence of complications. Compli-
cated acute aortic dissection Stanford type B (cAADB)
is associated with challenging visceral or peripheral
malperfusion, which is clinically apparent by abdominal
pain caused by (small-) bowel ischemia or renal infarction.
Untreated or delayed treatment beyond the duration of
visceral ischemia tolerance results in death. The main
goal is to resolve ischemia as soon as possible.
Traditionally, this scenario has been treated by replace-
ment of the descending aorta, fenestration procedures, and
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The Journal of Thoracic and Carhas replaced surgery as the treatment of choice. This has
been combined with insertion of uncovered stents into
compromised aortic branches.1-5
In the past 10 years, the insertion of covered stents into
the aortic true lumen (aTL) of the proximal descending
aorta has become increasingly popular to seal the entry
into the false lumen (FL).6-12 This concept has its
limitations, for example, in the presence of several
entries, which is not uncommon. In addition, it requires a
constantly available, well-trained team and a stock of
several aortic stent grafts to accommodate the variability
of aortic sizes. Placement of aortic stent grafts requires
large and stiff introducer systems. Given the texture of an
acute dissected aortic wall and distal vessels, this may result
in relevant vascular damage.
Malperfusion in cAADB is primarily caused by true
lumen (TL) collapse. Reexpansion of the TL by uncovered
stents should be effective in reestablishing visceral blood
flow and has been successfully performed in the past.
This approach requires only a 10F introducer system and
is therefore less traumatic than placement of stent grafts.OBJECTIVE
The purpose of this study was to retrospectively evaluate
the midterm clinical outcome after TL implantation ofdiovascular Surgery c Volume 148, Number 6 3003
Abbreviations and Acronyms
aTL ¼ aortic true lumen
cAADB ¼ complicated acute aortic dissection
Stanford type B
CTA ¼ computed tomographic angiography
FL ¼ false lumen
SMA ¼ superior mesenteric artery
TEVAR ¼ thoracic endovascular aortic/aneurysm
repair
TL ¼ true lumen
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Duncovered bare-metal stents without proximal entry tear
coverage for the treatment of visceral malperfusion and
peripheral ischemia in cAADB.
MATERIALS AND METHODS
This was a consecutive series of 14 patients (3 female, 11 male; mean
age, 58 11 years [range, 43-72 years]) with cAADBwhowere diagnosed
clinically with possible visceral ischemia. After Institutional Review Board
approval and patient’s informed consent, all patients underwent primary
interventional treatment for vital organ ischemia. The time interval
between acute chest pain and onset of abdominal symptoms varied from
5 hours to 3 days. All patients had acute abdominal pain with gastrointes-
tinal bleeding and/or diarrhea. In 6 patients, concomitant lower limb
ischemia was present. Renal ischemia was suspected in 6 patients because
of anuria and increased creatinine levels. Abnormal laboratory test results
(increased lactate, creatine kinase, lipase, amylase, and transaminase
levels) indicating ischemia were present in all patients (Table 1). cAADB
was confirmed by initial contrast-enhanced electrocardiography-gated
computed tomography (computed tomographic angiography [CTA]) of
the aorta including the supraaortic, iliac, and femoral arteries. In all cases,
CTA showed marked aTL compression (Figure 1). Relevant narrowing of
the visceral and/or iliac TL was observed in 9 patients.
Endovascular Treatment
Endovascular treatment was performed within 2 to 6 hours after the
onset of abdominal symptoms in all patients. No patient underwent
treatment later than this time interval. All patients underwent catheter
angiography via transfemoral access. The puncture site was chosen
according to the extent and course of dissection in the CTA to ensure TL
access. A pigtail catheter was placed into the abdominal aorta. The position
inside the TL was verified angiographically. In 1 case, puncture of the FL
occurred initially; subsequent TL access was established via the
contralateral femoral artery. Transbrachial access was not necessary in
any case.
The catheter was then advanced into the aortic arch for aortography. In
all 10 patients with relevant aTL compression as documented by CTA,
reduced flow to the TL was verified angiographically. The celiac axis
and superior mesenteric artery (SMA) arose from the collapsed TL
resulting in the typical angiographic sign of floating visceral arteries
(Figure 2).
In a further 4 cases, visceral malperfusion was caused by extension of
the dissection into the SMA or celiac trunk. The TL of the visceral arteries
was considerably stenosed by an enlarged FL.
In 5 patients, delayed or absent blood flow was observed in the common
iliac arteries.
Stent implantation into the aorta was performed in all 10 patients with
aTL compression to establish sufficient flow to visceral and iliac vessels
(Table 1).3004 The Journal of Thoracic and Cardiovascular SurLocalization for stent placement and sizing was based on CTA and
angiography. CTA was analyzed for morphology and to establish the
diameter of the aTL and aortic FL. Angiography was used for
hemodynamic assessment of functional compromise.
For aTL stenting, self-expanding bare-metal nitinol stents were used
(sinus-XL 10F, OptiMed Medizinische Instrumente GmbH, Ettlingen,
Germany), which are characterized by a closed-cell design with large
mesh size and high radial force. The dimension of 1 single cell is about
3 to 6 mm by 9 mm (width 3 length) depending on the stent diameter
(18-36 mm).
The stent size for aTL was chosen according to one quarter to one third
of the original cross-sectional aortic diameter including the TL and FL.
This intentional undersizing in relation to the original aortic diameter
was used to guarantee complete stent expansion. Only full stent expansion
in the optimal configuration assures the highest radial force.
Depending on the cranial extent of aTL compression, the first stent was
placed in the thoracoabdominal position with the distal end just above the
origin of the visceral arteries (n ¼ 6). One patient underwent stent
implantation into the middle descending thoracic aorta because of severe
aTL compression at that level. Two patients underwent stent implantation
just at the level of the visceral artery ostia. No compromise of visceral
artery inflow was observed by this overstenting of the visceral artery
lumina. This was true for the acute setting as well as for the follow-up at
2 years.
Inadequate blood flow to the inferior mesenteric and iliac arteries was
observed in 4 patients after insertion of a thoracoabdominal stent. This
was caused by aTL compression of the infrarenal aorta. These 4 patients
underwent additional infrarenal aortic stent implantation.
In order to ascertain complete expansion, all stents were dilated up to
the nominal stent diameter. Complete stent expansion was verified by
fluoroscopy in orthogonal planes. Angiography was used to evaluate
increased blood flow.
Stenting of compromised visceral arteries was performed with
balloon-expandable cobalt-chromium stents (n¼ 5) (Palmaz-Blue; Cordis,
Diegem, Belgium) in 4 patients. Stent oversizing was typically 10%.
Additional stents were placed distal to the renal arteries or aorto-iliacal
in the case of hemodynamically relevant stenosis as judged by clinically
apparent lower limb ischemia.
Early in the series, additional infrarenal fenestration of the dissection
was performed (n ¼ 4) for decompression of severe compromised aTL.
Access to the FL was obtained using a right-angled 5F catheter with a
0.89-mm (0.035-inch) stiff guidewire.13 The hard end of the guidewire
was used to perforate the dissection membrane under fluoroscopic
guidance. After verification of access to the FL by angiography, balloon
dilation (diameter 10 mm) was performed in order to expand the
perforation.
After intervention, all patients were transferred to an intensive care unit.
Close clinical monitoring focused on persistent or recurrent abdominal
pain or limb ischemia.
Postoperative imaging included ultrasonography of the visceral and
iliac arteries, and CTA after 1 week, 1, 3, and 6 months, and then every
12 months.
Data were analyzed using GraphPad Prism 6.0d for Mac (GraphPad
Software, Inc, La Jolla, Calif). Continuous variables were evaluated using
the Student t test.
RESULTS
Ten patients underwent implantation of 14 self-
expandable bare-metal stents (sinus-XL 10F and
sinus-Repo-Visual 6F, OptiMed; Bard LUMINEXX 6F,
C.R. Bard, Inc, Karlsruhe, Germany; WALLSTENT,
Boston Scientific, Marlborough, Mass) into the thoraco-
abdominal aorta (Table 2, Figures 3 and 4). In addition,gery c December 2014
TABLE 1. Laboratory results for the patients with complicated type B dissection
Laboratory values [normal limits]
Preintervention Maximum
Range Mean ± SD Range Mean ± SD
Creatine kinase [<167 U/L] 30-9853 1212  3066 110-126493 29,034  40,380
Lactic dehydrogenase [<289 U/L] 193-1300 372  354 239-10,494 2637  3506
Lactate [<2.2 mmol/L] 0.3-2.0 1.6  0.8 1.7-15 6.6  5.1
Creatinine [<1.2 mg/dL]* 0.49-1.9 1.3  0.5 0.9-15.5 4.6  4.7
Estimated glomerular filtration rate [mL/min/1.73 m2]* 35.8-110.3 58.6  24.8 3.4-60.9 24.5  18.6
C-reactive protein [<3 mg/L] 0.8-42.5 10.0  13.2 18.2-405.2 197.6  118.6
Because of different kinetics for the different parameters, baseline and maximum data are shown. SD, standard deviation. *Patients with dialysis-dependent chronic renal failure
are excluded.
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D9 self-expandable bare-metal stents (Luminexx-6F, Bard;
SinusVisualRepo-6F, Optimed) were placed into the
aortoiliac arteries (Table 2).
Fenestration of the dissection membrane was performed
in 4 patients. Satisfactory relief of visceral ischemia was
not obtained by fenestration alone in any patient. In
these cases, and in 1 patient with extreme intramural
hematoma of the thoracoabdominal aorta, additional
visceral artery stenting sufficiently improved visceral
perfusion; 4 patients underwent implantation of 5 balloon-
expandable cobalt-chromium stents (Palmaz-Blue) into
the mesenteric (n ¼ 3) or renal (n ¼ 2) arteries after aortic
fenestration. Details of the number, location, and stent type
for each patient are given in Table 2.
The primary technical success rate for stent implantation
was 100%. No peri-interventional complications occurred.
Follow-up CTA after 1 week revealed collapse of 4 aortic
stents (sinus-XL 10F; diameter, 9 mm, 20 mm, and 2 of
25 mm; length, 100 mm) in 4 patients (Figure 5). Two of
these patients received aortic fenestration for normalization
of the pressure gradient between aTL and FL before stent
implantation.
Successful catheter angiography with balloon dilation
was performed on all 4 stents. Nevertheless, all patientsFIGURE 1. A, Computed tomographic angiography shows a very small true lum
by the false lumen (asterisk). The dissection extends into the celiac trunk. B, Th
The aortic true lumen is almost completely collapsed (arrow).
The Journal of Thoracic and Carshowed recurrent collapse on follow-up CTA 1 month later.
In 1 of these stents, a fracture with complete disruption of
the stent struts was documented 3 months later (Figure 6).
All patients stabilized and remained asymptomatic
without the need for reintervention during the initial
hospital stay. Stenting resulted in marked clinical
improvement in all patients in the following 24 hours. There
was complete absence of abdominal pain and cessation of
claudication. No patients required additional interventional
or surgical therapy related to aortic dissection and its
sequelae during follow-up, which ranged from 6 to 124
months (mean  standard deviation, 45  47 months).
All patients with anuria caused by acute renal failure
(n ¼ 4) required dialysis; in 2 patients renal function
improved within a week. Two additional patients were
already in dialysis-dependent chronic renal failure before
the onset of aortic dissection. There was no patient with
new onset of chronic renal failure after interventional
treatment. Objective relief of visceral ischemia, for
example, normalization of lactic acidosis, was ascertained
by laboratory tests in all patients, including these with
previous chronic kidney disease.
There was no significant growth of the descending
thoracic aorta during follow-up. One patient showed anen (arrow) of the abdominal aorta, which is nearly completely compressed
e superior mesenteric artery ostium is covered by the dissection membrane.
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FIGURE 2. A, Catheter angiography after contrast medium injection into the aortic true lumen results in the typical appearance of floating visceral arteries.
B, Contrast injection into the aortic true lumen of the infrarenal aorta shows a high-grade stenosis due to almost complete compression of the true lumen.
Inflow into the iliac arteries is markedly reduced.
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Dincrease of 9 mm in the diameter of the abdominal aorta at
the level of the celiac trunk (27 mm vs 36 mm). In all other
cases the diameter of the abdominal aorta remained stable
(Figure 7). All FLs were patent without any relevant throm-
bosis. Ultrasonography and CTA showed patent perfusion
of the SMA in all patients and at every time point.
Two patients with enlargement of the ascending thoracic
aorta underwent replacement of the aortic valve and
ascending aorta for an ascending aortic aneurysm.
Freedom from aortic rupture or replacement of the
descending aorta was 100%. There were no neurologic
complications (eg, paraplegia, transient ischemic attack,TABLE 2. Number, type, and location of stent implantations in patients w
Region Patients Stents/patient
Thoracoabdominal aorta 9 Up to 4 sinu
sinu
WAL
Aorto-iliacal arteries 5 Up to 4 LUM
sinu
Visceral arteries 4 Up to 2 Palm
Celi
Supe
Ren
3006 The Journal of Thoracic and Cardiovascular Suror stroke). All patients are alive and well at the time of
this report.
DISCUSSION
cAADB is characterized by rupture or impending
rupture, malperfusion, refractory pain, or hypertension.
Organ ischemia is caused by obstruction of visceral or
peripheral arteries by the pressurized TL and dissection
membrane. Organ ischemia occurs in 30% to 50% of all
aortic dissections, and ischemia of the abdominal viscera
is one of the main causes of death in cAADB. The primary
objective is to reestablish sufficient aortic, visceral, andith complicated type B dissection
Stent type Stents Stent dimension
s-XL 10F (OptiMed) 12 Diameter 7-28 mm
Length 40-100 mms-Repo-Visual 6F (OptiMed) 1
LSTENT (Boston Scientific) 1
INEXX 6F (Bard) 8 Diameter 8-10 mm
Length 40-80 mms-Repo-Visual 6F (OptiMed) 1
az-Blue 4F (Cordis)
ac trunk (n ¼ 2)
rior mesenteric artery (n ¼ 1)
al artery (n ¼ 2)
5 Diameter 5-7 mm
Length 18-24 mm
gery c December 2014
FIGURE 3. A, Angiography reveals a complete occlusion of the superior mesenteric artery originating from the complete compression of the true aortic
lumen. B, Stent implantation into the true aortic lumen results in a markedly improved inflow into the superior mesenteric artery (asterisk) despite stent
placement over the superior mesenteric artery ostium. Because of impaired infrarenal blood flow, additional infrarenal stenting was performed.
Massmann et al Acquired Cardiovascular Disease
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Dperipheral artery blood flow by reexpansion of the
compressed TL. Optimal management of cAADB is still
controversial. Traditional treatment has been surgery with
either replacement of the dissected proximal thoracic
descending aorta or fenestration.14 Both approaches have
been associated with considerable morbidity and mortal-
ity.8,9,14,15 Descending aortic replacement has resulted in
greater than 30% mortality. Surgical fenestration has notFIGURE 4. A, Computed tomographic angiography depicts a slitlike configur
(asterisk). B, Adapted stent implantation achieved a perfused true lumen (X) o
The Journal of Thoracic and Caruniversally resulted in relief of end-organ ischemia16,17
and has also been associated with high mortality.9 Operative
mortality in the presence of visceral ischemia remains as
high as 70% to 80% either due to rupture or visceral
ischemia.18
Endovascular treatment has been introduced in the last 2
decades6 including implantation of stent grafts,8,10,19
catheter-based fenestration,13,17,20 or stenting of aortication of the true aortic lumen, which is compressed by a large false lumen
f about one quarter to one third of the original aortic diameter.
diovascular Surgery c Volume 148, Number 6 3007
FIGURE 5. A, Computed tomographic angiography initially reveals a compressed aortic true lumen. After stent implantation into the aortic true lumen,
computed tomographic angiography 2 weeks later shows stent collapse (arrows) in transverse (B) and sagittal (C) views.
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Dbranches.7 The objective is restoration and stabilization of
blood flow and dissection. Intimal flap mobility, aortic or
branch vessel obstruction, and perfusion of visceral organs
must be reproducibly improved without increasing the risk
of aortic rupture.7,10,17,20-22 In this context, the use of
thoracic endovascular aortic/aneurysm repair (TEVAR)
has been proposed to be beneficial for aortic remodeling;
but TEVAR had no positive effect on 2-year survival.19
Nevertheless, the main short-term goal is to establish and
ensure a patent TL for adequate blood supply to the visceral
arteries and lower extremities as fast as possible. TEVAR
attempts to achieve this goal by closing the proximal entry;
fenestration of the dissection membrane creates distal
reentries allowing the pressure gradient between the TL
and FL to be minimized, and stenting is meant to eliminate
the luminal occlusion of compressed aortic branches.
Using such endovascular approaches in an often
individualized fashion seems to have a beneficial effect
compared with open surgery.8,12,15,23 Aortic stent graft
implantation, fenestration, and stenting of the affected
aortic branches have thus become generally preferred in
cAADB.8,23-25 However, they still have drawbacks. The
use of interventional fenestration for the treatment of
malperfusion has had only variable success in3008 The Journal of Thoracic and Cardiovascular SurcAADB.13,16,17 Procedure-associated severe complications
include aortic perforation and rupture.26,27 In the past, we
have not been impressed with the clinical results. In our
current series, we used it in selected early cases, and
again its effect was not reproducible. With the positive
results of uncovered stenting, we have largely aborted
interventional/surgical fenestration. Stenting of aortic
branches has been primarily successful in limited
occlusion of these vessels. It does not, however, treat a
more general aTL collapse, which is frequently seen in
cAADB.
After the advent of TEVAR, simple stenting of the aorta
and visceral arteries was abandoned in many centers.
TEVAR has often been successful by closing the entry
site into the FL. Thereby, the pressure of the FL and TL
compression were minimized improving blood flow
through the aTL and into the visceral arteries. Most likely
due to the presence of reentries, its effect on aTL collapse
has not always been predictable. TEVAR may be difficult
to position in the presence of preexisting dilatation of the
descending aorta, which is not infrequent in cAADB.
Patency of the supraaortic vessels has to be maintained
and sometimes requires a hybrid procedure to ensure
perfusion of all supraaortic vessels, especially if dissectiongery c December 2014
FIGURE 6. A, Follow-up computed tomographic angiography of the patient in Figure 5, 2 weeks after stent implantation revealed stent collapse. B,
Balloon angioplasty resulted in a partial reexpansion of the stent. C, Follow-up computed tomographic angiography 4 weeks after reexpansion documents
recollapse. D, Follow-up computed tomographic angiography another 4 weeks after recollapse depicts complete disruption of the stent struts. Despite this
unsatisfactory morphologic result, the patient did not complain of clinical symptoms.
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Dinvolves the aortic arch. In addition, spinal ischemia is a
known risk factor with TEVAR. Stent grafts have the
disadvantage of requiring relatively stiff and large
introducer systems. Retrograde aortic dissection involving
the ascending aorta and perforations have been reported,
which were most likely related to the fragile texture of the
sub-/acutely dissected aorta.28
Even after correct stent graft implantation, aTL collapse
may persist despite obliteration of the proximal thoracic
aortic entry tear.20 Although current interventional
approaches have been successful, current techniques still
seem suboptimal. An optimal approach should involve
less invasive introducer systems of smaller diameter.
Inadequate iliac access vessels with atherosclerotic disease
are a technical contraindication for TEVAR.
If there is a need for additional aortic and visceral artery
stenting after TEVAR, the question has to be asked whether
TEVARoffers anybenefits over the initial and sole treatment
of distal aortic and visceral artery stenting, especially when
the additional potential complications of TEVAR compared
with stenting alone are taken into consideration.The Journal of Thoracic and CarBecause TL compression seems to be of central
importance in cAADB with visceral malperfusion, we
hypothesized that TL stenting should be effective in
alleviating visceral ischemia. The above-mentioned
disadvantages of stent grafts prompted us to evaluate the
application of uncovered stents for the treatment of visceral
malperfusion. Uncovered stents have more flexible delivery
systems with small low-profile 10F (3 mm) delivery
systems. Therefore, insertion and positioning is atraumatic
and technically relatively easy. Covered stent grafts require
a diameter of 20 to 24F (7-8 mm), which results in a much
higher shear stress to iliac access vessels, especially in
unfavorable tortuous anatomy.
Covering of abdominal branch vessels is tolerable, if
needed to alleviate malperfusion. No reduced inflow to
visceral arteries was observed in any of our cases, due to
the relatively wide mesh structure of the stent struts.
Nonetheless, we usually try to avoid aortic stent placement
over visceral artery ostia.
We observed 4 cases of stent collapse after decompress-
ing a slitlike compressed aTL at the thoracoabdominaldiovascular Surgery c Volume 148, Number 6 3009
FIGURE 7. Aortic diameter on initial and follow-up computed
tomographic angiography: box and Whiskers plot (min/max/25th percen-
tiles) with P values. asc, Ascending; FU, follow-up; desc, descending.
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Dlevel. One stent reexpanded spontaneously. Reexpansion by
balloon angioplasty was temporarily successful in 3, but
recollapse was seen a few weeks later on follow-up
computed tomography. The underlying cause for this stent
collapse is most likely related to inadequate radial forces
of the stent. One the one hand, there is a perpetual pulsatile
pressure in the FL because the primary entry tear is not
treated. Despite additional fenestration for normalization
of the pressure gradient, stent collapse occurred in 2 of these
4 patients. Even though the exact mechanism could not be
clarified, its occurrence did not lead to any negative clinical
results, possibly because of preservation of sufficient blood
flow. The reason for the positive clinical results may be
related to preservation of sufficient flow in the rounded
corners of the collapsed stent (Figure 5, A). Alternatively,
stent collapse may have developed gradually, allowing for
collateral blood flow to develop.
In order to minimize the occurrence of stent collapse,
nowadays we choose aortic stents with a smaller diameter.
This intentional undersizing in relation to the original aortic
diameter allows complete stent expansion resulting in a
rounded shape and optimal radial force. This configuration
should allow the stents to bear the highest radial pressure.
The radial force of an incompletely inflated stent will
always be much lower than a perfectly expanded stent.
Determination of appropriate stent size is difficult.
According to our experience, a stent diameter of about
one quarter to one third of the original aortic diameter is
favorable. Oversizing should be avoided; the stent should
not be chosen to achieve the original diameter of the aorta.
Instead, it should only open the TL for a break through of
the initial ischemic phase.
Usually, stent undersizing can lead to stent displacement.
In aortic dissection, however, the forces of the dissection3010 The Journal of Thoracic and Cardiovascular Surmembrane are sufficient to secure an undersized stent in
place.
In addition, interventional treatment leads to stabilization
of the descending aortic diameter. The diameter of the
abdominal aorta showed no statistically significant increase
after a mean follow-up of 3 years. Only replacement of the
ascending aorta and aortic valve was necessary in 2 patients
for concomitant ascending aortic aneurysm. No thrombosis
of the aortic FL occurred. Although this, in conjunction
with remodeling, is one of the arguments for a TEVAR,
we could not see any disadvantage of a still-perfused FL.
Neither increasing aortic aneurysms nor ulcers were seen
during follow-up. The results are at least as effective
as covered stent placement into the aorta or aortic branches
alone or as an adjunct to percutaneous fenestration.5,25,29,30
The limitations of this study are mainly its small sample
size and retrospective nature. It is impossible to say which
endovascular treatment is best for cAADB from our results.
The aggressive approach to treating potentially ischemic
regions is consistent with our intention to avoid any delay
in treatment, which may lead to irreversible damage. All
patients were treated before development of acidosis and
shock, and we contribute our favorable results to the fact
that very early intervention avoided the fatal scenario of
intestinal gangrene.
The positive results stress the point that even an older
technique like uncovered stent placement may be a viable
alternative to stent grafts. This is especially important for
those hospitals where logistic requirements cannot be
fulfilled and sufficient knowledge of aortic stent graft
placement is not available.
In conclusion, thoracoabdominal uncovered stent
implantation is a technically feasible and effective therapy
in cAADB. The study provides a strong case for very early
intervention in patients with acute aortic dissection if there
is a suspicion of visceral ischemia. Uncovered stent
implantation provided successful relief of acute visceral
ischemia or claudication and yielded a similar if not better
clinical outcome during midterm follow-up compared with
the literature data on TEVAR. Stent size should be adapted
to about one third of the original aortic diameter. Stents with
high radial force should be used to avoid stent collapse.
Uncovered stent implantation did not lead to progressive
aortic expansion at midterm follow-up.References
1. Chavan A, Rosenthal H, Luthe L, Pfingsten S, Kutschka I, Easo J, et al.
Percutaneous interventions for treating ischemic complications of aortic
dissection. Eur Radiol. 2009;19:488-94.
2. Lauterbach SR, Cambria RP, Brewster DC, Gertler JP, Lamuraglia GM,
Isselbacher EM, et al. Contemporary management of aortic branch compromise
resulting from acute aortic dissection. J Vasc Surg. 2001;33:1185-92.
3. Beregi J-P, Haulon S, Otal P, Thony F, Bartoli J-M, Crochet D, et al.
Endovascular treatment of acute complications associated with aortic
dissection: midterm results from a multicenter study. J Endovasc Ther. 2003;
10:486-93.gery c December 2014
Massmann et al Acquired Cardiovascular Disease
C
D4. Slonim SM, Nyman UR, Semba CP, Miller DC, Mitchell RS, Dake MD. True
lumen obliteration in complicated aortic dissection: endovascular treatment.
Radiology. 1996;201:161-6.
5. Williams DM, Lee DY, Hamilton BH, Marx MV, Narasimham DL,
Kazanjian SN, et al. The dissected aorta: percutaneous treatment of ischemic
complications–principles and results. J Vasc Interv Radiol. 1997;8:605-25.
6. Fann JI, Sarris GE, Mitchell RS, Shumway NE, Stinson EB, Oyer PE, et al.
Treatment of patients with aortic dissection presenting with peripheral vascular
complications. Ann Surg. 1990;212:705-13.
7. Sfyroeras GS, Rubio V, Pagan P, Diethrich EB, Rodriguez JA. Endovascular
management of malperfusion in acute type B aortic dissections. J Endovasc
Ther. 2011;18:78-86.
8. Fattori R, Tsai TT, Myrmel T, Evangelista A, Cooper JV, Trimarchi S, et al.
Complicated acute type B dissection: is surgery still the best option? A report
from the International Registry of Acute Aortic Dissection. JACC Cardiovasc
Interv. 2008;1:395-402.
9. Laas J, Heinemann M, Schaefers HJ, Daniel W, Borst HG. Management of
thoracoabdominal malperfusion in aortic dissection. Circulation. 1991;
84(5 Suppl):III20-4.
10. Svensson LG, Kouchoukos NT,Miller DC, Bavaria JE, Coselli JS, CuriMA, et al.
Expert consensus document on the treatment of descending thoracic aortic disease
using endovascular stent-grafts. Ann Thorac Surg. 2008;85(1 Suppl):S1-41.
11. Swee W, Dake MD. Endovascular management of thoracic dissections.
Circulation. 2008;117:1460-73.
12. Zeeshan A, Woo EY, Bavaria JE, Fairman RM, Desai ND, Pochettino A, et al.
Thoracic endovascular aortic repair for acute complicated type B aortic
dissection: superiority relative to conventional open surgical and medical therapy.
J Thorac Cardiovasc Surg. 2010;140(6 Suppl):S109-15; discussion S142-6.
13. Hartnell GG, Gates J. Aortic fenestration: a why, when, and how-to guide.
Radiographics. 2005;25:175-89.
14. Heinemann MK, Buehner B, Schaefers HJ, Jurmann MJ, Laas J, Borst HG.
Malperfusion of the thoracoabdominal vasculature in aortic dissection. J Card
Surg. 1994;9:748-55; discussion 755-7.
15. Wilkinson DA, Patel HJ, Williams DM, Dasika NL, Deeb GM. Early open and
endovascular thoracic aortic repair for complicated type B aortic dissection.
Ann Thorac Surg. 2013;96:23-30; discussion 230.
16. Pradhan S, Elefteriades JA, Sumpio BE. Utility of the aortic fenestration
technique in the management of acute aortic dissections. Ann Thorac Cardiovasc
Surg. 2007;13:296-300.
17. Midulla M, Renaud A, Martinelli T, Koussa M, Mounier-Vehier C, Prat A, et al.
Endovascular fenestration in aortic dissection with acute malperfusion
syndrome: immediate and late follow-up. J Thorac Cardiovasc Surg. 2011;
142:66-72.The Journal of Thoracic and Car
A18. Von Kodolitsch Y, Schwartz AG, Nienaber CA. Clinical prediction of acute aortic
dissection. Arch Intern Med. 2000;160:2977-82.
19. Nienaber CA, Rousseau H, Eggebrecht H, Kische S, Fattori R, Rehders TC, et al.
Randomized comparison of strategies for type B aortic dissection: the
INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial.
Circulation. 2009;120:2519-28.
20. Slonim SM, Miller DC, Mitchell RS, Semba CP, Razavi MK, Dake MD.
Percutaneous balloon fenestration and stenting for life-threatening ischemic
complications in patients with acute aortic dissection. J Thorac Cardiovasc
Surg. 1999;117:1118-26.
21. Nienaber CA, Kische S, Zeller T, Rehders TC, Schneider H, Lorenzen B, et al.
Provisional extension to induce complete attachment after stent-graft placement
in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther. 2006;13:
738-46.
22. Fattori R, Botta L, Lovato L, Biagini E, Russo V, Casadei A, et al. Malperfusion
syndrome in type B aortic dissection: role of the endovascular procedures. Acta
Chir Belg. 2008;108:192-7.
23. Szeto WY, McGarvey M, Pochettino A, Moser GW, Hoboken A, Cornelius K,
et al. Results of a new surgical paradigm: endovascular repair for acute
complicated type B aortic dissection. Ann Thorac Surg. 2008;86:87-93;
discussion 93-4.
24. Eggebrecht H, L€onn L, Herold U, Breuckmann F, Leyh R, Jakob HG, et al.
Endovascular stent-graft placement for complications of acute type B aortic
dissection. Curr Opin Cardiol. 2005;20:477-83.
25. Fattori R, Nienaber CA, Rousseau H, Beregi J-P, Heijmen R, Grabenw€oger M,
et al. Results of endovascular repair of the thoracic aorta with the Talent Thoracic
stent graft: the Talent Thoracic Retrospective Registry. J Thorac Cardiovasc
Surg. 2006;132:332-9.
26. Lookstein RA, Mitty H, Falk A, Guller J, Nowakowski FS. Aortic intimal
dehiscence: a complication of percutaneous balloon fenestration for aortic
dissection. J Vasc Interv Radiol. 2001;12:1347-50.
27. Maynar M, Rostagno R, Zander T, Qian Z, Llorens R, Zerolo I, et al. Intimal
dehiscence in the abdominal aorta following balloon fenestration for type B
dissection. J Endovasc Ther. 2005;12:103-9.
28. Kolluri R, Fowler B, Nandish S. Vascular access complications:
diagnosis and management. Curr Treat Options Cardiovasc Med. 2013;
15:173-87.
29. Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK, Shimono T, et al.
Endovascular stent-graft placement for the treatment of acute aortic dissection.
N Engl J Med. 1999;340:1546-52.
30. Nienaber CA, Fattori R, Lund G, Dieckmann C, Wolf W, von Kodolitsch Y, et al.
Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement.
N Engl J Med. 1999;340:1539-45.diovascular Surgery c Volume 148, Number 6 3011
